TrialAmerican journal of hematology2020

Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.

Najibah A Galadanci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.